Return On Equity of Amphastar Pharmaceuticals, Inc. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Amphastar Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • Amphastar Pharmaceuticals, Inc. Return On Equity for the quarter ending 31 Dec 2025 was 13%, a 43% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2025 was 13%, a 43% decline from 2024.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2024 was 22%, a 3.3% decline from 2023.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2023 was 23%, a 28% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Amphastar Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 13% -9.7% -43% 01 Oct 2025 31 Dec 2025
Q3 2025 15% -8.1% -35% 01 Jul 2025 30 Sep 2025
Q2 2025 18% -7.3% -29% 01 Apr 2025 30 Jun 2025
Q1 2025 19% -5.4% -22% 01 Jan 2025 31 Mar 2025
Q4 2024 22% -0.77% -3.3% 01 Oct 2024 31 Dec 2024
Q3 2024 23% -1% -4.2% 01 Jul 2024 30 Sep 2024
Q2 2024 25% +6.6% +35% 01 Apr 2024 30 Jun 2024
Q1 2024 25% +6.9% +38% 01 Jan 2024 31 Mar 2024
Q4 2023 23% +5% +28% 01 Oct 2023 31 Dec 2023
Q3 2023 24% +7.9% +49% 01 Jul 2023 30 Sep 2023
Q2 2023 19% -0.83% -4.2% 01 Apr 2023 30 Jun 2023
Q1 2023 18% +0.05% +0.29% 01 Jan 2023 31 Mar 2023
Q4 2022 18% +4.3% +31% 01 Oct 2022 31 Dec 2022
Q3 2022 16% +8% +99% 01 Jul 2022 30 Sep 2022
Q2 2022 20% +17% +752% 01 Apr 2022 30 Jun 2022
Q1 2022 18% +17% +3107% 01 Jan 2022 31 Mar 2022
Q4 2021 14% +14% +4257% 01 Oct 2021 31 Dec 2021
Q3 2021 8% +6.5% +427% 01 Jul 2021 30 Sep 2021
Q2 2021 2.3% +1.4% +146% 01 Apr 2021 30 Jun 2021
Q1 2021 0.56% -12% -95% 01 Jan 2021 31 Mar 2021
Q4 2020 0.32% -11% -97% 01 Oct 2020 31 Dec 2020
Q3 2020 1.5% -11% -88% 01 Jul 2020 30 Sep 2020
Q2 2020 0.94% -13% -93% 01 Apr 2020 30 Jun 2020
Q1 2020 12% +11% +1772% 01 Jan 2020 31 Mar 2020
Q4 2019 12% +13% 01 Oct 2019 31 Dec 2019
Q3 2019 13% +15% 01 Jul 2019 30 Sep 2019
Q2 2019 14% +17% 01 Apr 2019 30 Jun 2019
Q1 2019 0.65% +1.7% 01 Jan 2019 31 Mar 2019
Q4 2018 -1.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -1.9% 01 Jul 2018 30 Sep 2018
Q2 2018 -2.6% 01 Apr 2018 30 Jun 2018
Q1 2018 -1.1% 01 Jan 2018 31 Mar 2018

Amphastar Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 13% -9.7% -43% 01 Jan 2025 31 Dec 2025
2024 22% -0.77% -3.3% 01 Jan 2024 31 Dec 2024
2023 23% +5% +28% 01 Jan 2023 31 Dec 2023
2022 18% +4.3% +31% 01 Jan 2022 31 Dec 2022
2021 14% +14% +4257% 01 Jan 2021 31 Dec 2021
2020 0.32% -11% -97% 01 Jan 2020 31 Dec 2020
2019 12% +13% 01 Jan 2019 31 Dec 2019
2018 -1.7% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.